Joseph Koenigsmark
Addiction Medicine · Shepherdsville, KYNPI 1437214731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $696, 2.9 times the $237 reported in 2019.
Across 195 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$684
- AbbVie$625
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$413
- Orexo US, Inc.$409
- Indivior Inc.$270
- Vanda Pharmaceuticals Inc.$196
- plus $750 from 18 others
What the payments were for
- Food & beverage$3,346100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 36 | $684 |
| AbbVie | 47 | $625 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $413 |
| Orexo US, Inc. | 26 | $409 |
| Indivior Inc. | 16 | $270 |
| Vanda Pharmaceuticals Inc. | 12 | $196 |
| Gilead | 5 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $100 |
| MDD US Operations, LLC | 3 | $74 |
| Neurocrine Biosciences, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $51 |
| Braeburn Inc. | 3 | $49 |
| Amgen | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Almatica Pharma LLC | 2 | $36 |
| USWM, LLC | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Corium, LLC | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Tris Pharma Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,346 in reported general payments places this provider in the 85th percentile of 40 addiction medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 135 | $24,070 |
| VraylarCariprazine Hcl | 14 | $19,099 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 11 | $18,113 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $6,668 |
| Buprenorphine Hcl | 62 | $2,130 |
| Gabapentin | 25 | $293 |
| Clonazepam | 44 | $287 |
| Lamotrigine | 20 | $181 |
| Alprazolam | 13 | $83 |
| Buspirone Hcl | 14 | $14 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $625 | $19,09914 claims |
| Orexo US, Inc.Zubsolv | $409 | $18,11311 claims |
| Indivior Inc.Suboxone | $270 | $6,66814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 40 addiction medicine providers in Kentucky.
Other addiction medicine in Shepherdsville
- Anastasia JandesLexington$55K
- Rallie McAllisterLexington$17K
- Michael KindredLexington$13K
- Asad IsmailLouisville$10K
- Guy LernerElizabethtown$10K
- Teresa KoellerCovington$3K
- Oliver BenesCovington$3K
- Barry HardisonCentral City$3K
- Kathryn RutlandLouisville$3K
- Mina KalfasCovington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.